WallStreetZenWallStreetZen

NASDAQ: PALI
Palisade Bio Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Be the first to know when Wall Street analysts revise their PALI stock forecasts and price targets.

Forecast return on equity

Is PALI forecast to generate an efficient return?

Company
-1,703.42%
Industry
254.36%
Market
227.38%
PALI's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is PALI forecast to generate an efficient return on assets?

Company
-784.65%
Industry
89.85%
PALI is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

PALI earnings per share forecast

What is PALI's earnings per share in the next 3 years based on estimates from 5 analysts?

Avg 1 year Forecast
-$1.06
Avg 2 year Forecast
-$0.59
Avg 3 year Forecast
-$0.65

PALI revenue forecast

What is PALI's revenue in the next 3 years based on estimates from 5 analysts?

Avg 1 year Forecast
$0.0
Avg 2 year Forecast
$0.0
Avg 3 year Forecast
$0.0

PALI vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
PALI$1.90N/AN/A
ABEO$5.24$20.00+281.68%Buy
OABI$1.99$3.00+50.75%Buy
PBYI$5.52N/AN/A
ALDX$4.79$9.00+87.89%Strong Buy
View Top Biotech Stocks

Palisade Bio Stock Forecast FAQ

What is PALI's earnings growth forecast for 2025-2027?

(NASDAQ: PALI) Palisade Bio's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 43.87%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 42.62%.

Palisade Bio's earnings in 2025 is -$11,226,000.On average, 5 Wall Street analysts forecast PALI's earnings for 2025 to be -$158,569,216, with the lowest PALI earnings forecast at -$268,682,588, and the highest PALI earnings forecast at -$28,161,607. On average, 5 Wall Street analysts forecast PALI's earnings for 2026 to be -$87,643,688, with the lowest PALI earnings forecast at -$178,148,238, and the highest PALI earnings forecast at -$25,032,539.

In 2027, PALI is forecast to generate -$96,762,685 in earnings, with the lowest earnings forecast at -$178,148,238 and the highest earnings forecast at -$26,597,073.

If you're new to stock investing, here's how to buy Palisade Bio stock.

What is PALI's revenue growth forecast for 2025-2027?

(NASDAQ: PALI) Palisade Bio's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 102.73%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 25.81%.

Palisade Bio's revenue in 2025 is $0.On average, 5 Wall Street analysts forecast PALI's revenue for 2025 to be $0, with the lowest PALI revenue forecast at $0, and the highest PALI revenue forecast at $0. On average, 5 Wall Street analysts forecast PALI's revenue for 2026 to be $0, with the lowest PALI revenue forecast at $0, and the highest PALI revenue forecast at $0.

In 2027, PALI is forecast to generate $0 in revenue, with the lowest revenue forecast at $0 and the highest revenue forecast at $0.

What is PALI's forecast return on assets (ROA) for 2025-2028?

(NASDAQ: PALI) forecast ROA is -784.65%, which is lower than the forecast US Biotechnology industry average of 89.85%.

What is PALI's Earnings Per Share (EPS) forecast for 2025-2027?

(NASDAQ: PALI) Palisade Bio's current Earnings Per Share (EPS) is -$2.12. On average, analysts forecast that PALI's EPS will be -$1.06 for 2025, with the lowest EPS forecast at -$1.80, and the highest EPS forecast at -$0.19. On average, analysts forecast that PALI's EPS will be -$0.59 for 2026, with the lowest EPS forecast at -$1.20, and the highest EPS forecast at -$0.17. In 2027, PALI's EPS is forecast to hit -$0.65 (min: -$1.20, max: -$0.18).

What is PALI's forecast return on equity (ROE) for 2025-2028?

(NASDAQ: PALI) forecast ROE is -1,703.42%, which is considered weak.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.